doravirine
Doravirine, sold under the brand name Pifeltro, is a non-nucleoside reverse transcriptase inhibitor medication developed by Merck & Co. for use in the treatment of HIV/AIDS.
Article
2 sectionsContents
- Synthesis
- References
{{Drugbox | image = Doravirine.svg | image_class = skin-invert-image | alt = | caption =
| tradename = Pifeltro | Drugs.com = | MedlinePlus = a618048 | DailyMedID = Doravirine | pregnancy_AU = | pregnancy_category = | routes_of_administration = By mouth | ATC_prefix = J05 | ATC_suffix = AG06 | ATC_supplemental =